Around one in every 100 people worldwide has vitiligo—a chronic, autoimmune skin condition that causes the skin to appear lighter in patches.
May 20, 2026
0
3
In a consensus statement published online March 25 in JAMA Dermatology, internationally agreed-upon severity criteria are presented for vitiligo.
Apr 2, 2026
0
4
Researchers at The Jackson Laboratory (JAX), in collaboration with the Massachusetts Institute of Technology (MIT), have developed the first bandage-like microneedle patch that can sample the body's immune responses painlessly ...
Mar 2, 2026
0
496
A David Geffen School of Medicine at UCLA-led research team reports that vitiligo is associated with increased depression risk, with higher risk among Black and Hispanic patients.
The combination of a targeted oral medication with light therapy may enhance repigmentation for patients living with nonsegmental vitiligo, a team of researchers led by Emma Guttman-Yassky, MD, Ph.D., Waldman Professor and ...
Apr 14, 2025
0
44
Narrowband UVB (nbUVB) phototherapy may be underutilized in pediatric vitiligo, according to a study published online March 18 in Pediatric Dermatology.
Apr 8, 2025
0
17
A natural compound derived from gut-friendly bacteria significantly slows the progression of vitiligo and may restore pigmentation, reports a new Northwestern University pre-clinical study in mice.
Jan 28, 2025
0
45
Skin pigmentation disorders affect people across the world. One of them, vitiligo, is said to have a worldwide incidence of 1–2%. What causes the loss of pigmentation in vitiligo has long been unclear, but an Osaka Metropolitan ...
Sep 9, 2024
0
36
A unique chicken breed is helping researchers better understand vitiligo, an autoimmune disease that affects 1–2% of the world's population.
Aug 29, 2024
0
44
Scientists at deCODE genetics have published a study in Nature Communications, comparing over 110 thousand patients with autoimmune thyroid disease (AITD) from Iceland, Finland, UK and U.S. with 1.1 million controls. The ...
Jul 12, 2024
0
67
